NCT03485157 - Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee | Biotech Hunter

Enrollment

447

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

April 19, 2022

Study Completion Date

April 19, 2022

Conditions

Knee Osteoarthritis

Interventions

BIOLOGICAL

Micronized dHACM

Injection of 40 mg micronized dehydrated human amnion chorion membrane (dHACM) suspended in 1 mL 0.9% Sodium Chloride, USP

DRUG

Saline

Injection of 1 mL 0.9% Sodium Chloride, USP

Trial Locations (17)

10065

Weill Cornell Medicine, New York

16602

University Orthopedics Center, Altoona

16801

University Orthopedics Center, State College

21046

Arthritis Care Specialist of Maryland, Columbia

23294

Ortho Virginia, Richmond

27612

Wake Research, Raleigh

27704

Wake Reseach, Durham

30327

Paragon Sports Medicine, Atlanta

34232

Gulfcoast Research Institute, Sarasota

35205

Central Research Associates, Inc, Birmingham

48106

MedSport, Ann Arbor

60521

Hinsdale Orthopedics, Hinsdale

78234

SAMMC, Fort Sam Houston

85283

Fiel Family and Sports Medicine, Tempe

91942

Horizon Clinical Research, La Mesa

06030

UConn Health, Farmington

06106

Bone & Joint Inst. at Hartford Hospital, Hartford

All Listed Sponsors

lead

MiMedx Group, Inc.

INDUSTRY